Potentially Groundbreaking CAR-T Product Shows Early Promise in Lupus



(MedPage Today) — Five patients with systemic lupus erythematosus (SLE) in China have been treated with a potentially groundbreaking form of chimeric antigen receptor (CAR) T-cell therapy, researchers reported, with encouraging results after 3…



Source link : https://www.medpagetoday.com/rheumatology/lupus/117504

Author :

Publish date : 2025-09-17 21:00:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version